醫藥

Leader_Big pharma teams up with big data
FT社評:大數據與醫學融合尚存障礙


谷歌和諾華開啓了大藥商與大數據的聯姻,雙方將合作開發如監測血糖水準的智慧隱形眼鏡等一系列設備。但將新技術推向市場並非易事,需要面臨監管、社會和倫理等問題。

Big pharma and Silicon Valley have been circling one another for some time, looking for ways in which they might harness the power of data technology to medical ends. Now a fusion of West Coast entrepreneurship and lab-coated medical expertise has spawned its first big publicly announced transaction. Google has struck a deal with Novartis to develop a “smart” contact lens designed to help diabetics track their blood sugar levels.

大藥商和矽谷之間互相關注已經有一段時間了,他們試圖利用數據技術爲醫療目的服務。現在,美國西海岸的創業精神和實驗室白大褂象徵的醫療技術走到一起,催生了首個公開宣佈的交易。谷歌(Google)與諾華(Novartis)達成協議,將共同開發一款「智慧」隱形眼鏡,幫助糖尿病患者追蹤血糖水準。

您已閱讀12%(575字),剩餘88%(4177字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×